| 前收市價 | 0.4500 |
| 開市 | 0.3500 |
| 買盤 | 0.0000 |
| 賣出價 | 0.5000 |
| 拍板 | 2.50 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 0.3000 - 0.4600 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 1.18k |
ZacksAllogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
Allogene (ALLO) reports drab first-quarter 2024 results. The company secures the development and marketing rights to its CD19 oncology program in Europe.
ZacksAllogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates
Allogene Therapeutics (ALLO) delivered earnings and revenue surprises of 0% and 47.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksCollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock?
CollPlant Biotechnologies (CLGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
